Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (9): 1-9    DOI:
    
Rescue of the Minigenome of Human Respiratory Syncytial Virus Based on T7 Promoter Expression System
YUAN Rui1,2, FU Yuan-hui2, HE Jin-sheng2, JIAO Yue-ying2, JIANG Gui-yun1,2, ZHANG Mei1, PENG Xiang-lei2, KAN Xue-tong 1,2
1. Department of Immunology, Anhui Medical University, Hefei 230032, China;
2. College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China
Download: HTML   PDF(869KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective:To establish a T7 promoter based reverse genetics system competent for the rescue of human respiratory syncytial virus. Methods:We construct four helper plasmids of px8δT-PT1-N, px8δT-PT1-P, px8δT-PT1-M2-1 and px8δT-PT1-L encoding RSV nucleocapsid proteins, respectively, and one minigenome plasmid of pSC11-E containing open reading frame of the enhanced green flurorecent protein and cis-acting elements including RSV leader region/promoter, gene start, gene end and trailer region/antigenomic promoter. All these plasmids are under the control of T7 promoter and identified by restriction endonucleoase analysis and Western blot. The pSC11-E is rescued by RSV and the above helper plasmids in BSR T7/5 cells, respectively. Then, the fluorescence expression is observed over time with fluorescence microscopy. Results:We successfully constructed a reverse genetics system based 5 plasmids undert the control of T7 promoter and finished the rescue operation to the minigenome of RSV. Conclusion:This system can be further applied to investigate the function of RSV genome by deletion and mutation of its genes.

Key wordsHuman respiratory syncytial virus      Minigenome      Reverse genetics     
Received: 25 April 2013      Published: 25 September 2013
ZTFLH:  Q34  
Cite this article:

YUAN Rui, FU Yuan-hui, HE Jin-sheng, JIAO Yue-ying, JIANG Gui-yun, ZHANG Mei, PENG Xiang-lei, KAN Xue-tong. Rescue of the Minigenome of Human Respiratory Syncytial Virus Based on T7 Promoter Expression System. China Biotechnology, 2013, 33(9): 1-9.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I9/1

[1] Yoshihiko M. Respiratory syncytial virus vaccine development. Clin Lab Med, 2009, 29(4): 725-739.
[2] Beeler J A, Eichelberger M C. Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy. Microb Pathogenesis, 2013, 55: 9-15.
[3] Chang J. Current progress on development of respiratory syncytial virus. BMB Rep, 2011, 44(4): 232-237.
[4] Collins P L, Melero J A. Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years. Virus Res, 2011, 162(1-2): 80-99.
[5] Collins P L, Crowe J E Jr.Respiratory syncytial virus and metapneumovirus. In: Knipe D M, Howley P M, Griffin D E, et a1. Fields Virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2007. 1601-1646.
[6] 何金生,付远辉,洪涛. 人呼吸道合胞病毒活疫苗研究进展. 中国科学,2011,41(1): 1-12. He J SH, Fu Y H, Hong T. Live vivus vaccines against human respiratory syncytial virus. Scientia Sinica Vitae, 2011, 41(1): 1-12.
[7] 虞结梅,何金生,李栋梁,等. 人呼吸道合胞病毒RNA聚合酶复合体蛋白N、P的克隆和表达鉴定. 中国病毒学, 2006, 21(3): 213-216. Yu J M,He J SH,Li D L,et al. Expression and identification of Nucleoprotein and phosphoprotein of RNA ploymerase complex of human respiratory syncytial virus. Virologica Sinica, 2006, 21(3): 213-216.
[8] 虞结梅,杨兵,谢灿,等. T7 RNA聚合酶的克隆及其介导基因转录功能的鉴定. 安徽医科大学学报, 2007, 42(3): 272-275. Yu J M,Yan B,Xie C,et al. Clone and function of transcriptase identified of T7 RNA ploymerase.Acta Universitatis Medicinalis Anhui, 2007, 42(3): 272-275.
[9] 唐倩,虞结梅,何金生,等. 人呼吸道合胞病毒微型复制子的构建. 微生物学报, 2009, 49(8): 1048-1054. Tang Q, Yu J M, He J SH, et al. Construction of minireplicon of human respiratory syncytial virus. Acta Microbiologica Sinica, 2009, 49(8): 1048-1054.
[10] Fearns R, Collins P L. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol, 1999, 73(7): 5852-5864.
[11] Collins P L, Whitehead S S, Bukreyev A, et al. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv. Virus Res, 1999, 54, 324-351.
[12] Bermingham A, Collins P L. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A,1999, 96(20): 11259-11264.
[13] Pattnaik A K, Ball L A, LeGrone A W, et al. Infectious defective interfering particles of VSV from transcripts of a cDNA clone. Cell, 1992, 69(6): 1011-1020.
[14] Ghanem A, Kern A, Conzelmann K K. Significantly improved rescue of rabies virus from cDNA plasmids. Eur J Cell Biol,2012,91(1):10-16.
[15] Buchholz U J, Finke S, Conzelmann K K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol, 1999, 73(1): 251-259.
[16] Grosfeld H, Hill M G, Collins P L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol, 1995, 69(9): 5677-5686.
[17] Collins P L, Hill M G, Camargo E, et al. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA and provides a capability for vaccine development. Proc Natl Acad Sci USA, 1995, 92(25): 11563-11567.
[18] Samal S K, Collins P L. RNA Replication by a respiratory syncytial virus RNA analog does not obey the rule of six and retains a nonviral trinucleotide extension at the leader end. J Virol, 1996, 70(8): 5075-5082.
[19] Bradrick S S, Dobrikova E Y, Kaiser C, et al. Poly(A)-binding protein is differentially required for translation mediated by viral internal ribosome entry sites. RNA, 2007, 13(9): 1582-1593.
[20] Kieft J S. Viral IRES RNA structures and ribosome. Trends Biochem Sci, 2008, 33(6): 274-283.
[21] Kaur J, Tang R S, Spaete R R, et al. Optimization of plasmid-only rescue of highly attenuated and temperature-sensitive respiratory syncytial virus (RSV) vaccine candidates for human trials. J Virol Methods, 2008, 153(2): 196-202.
[22] Witko S E, Kotash C S, Nowak R M, et al. An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development. J Virol Methods, 2006, 135(1): 91-101.
[23] Parks C L, Lerch R A, Walpita P,et al.Enhanced measles virus cDNA rescue and gene expression after heat shock. J Virol, 1999, 73(5): 3560-3566.
[1] LIU Mei-qin,GAO Bo,JIAO Yue-ying,LI Wei,YU Jie-mei,PENG Xiang-lei,ZHENG Yan-peng,FU Yuan-hui,HE Jin-sheng. Long Non-coding RNA Expression Profile in A549 Cells Infected with Human Respiratory Syncytial Virus[J]. China Biotechnology, 2021, 41(2/3): 7-13.
[2] SHEN Liang, TAN Wen-jie. Progress on the Technique and its Application of Reverse Genetics for Coronaviruses[J]. China Biotechnology, 2015, 35(2): 84-91.
[3] ZHANG Mei, WANG Xiao-bo, FU Yuan-hui, FANG Xuan, WANG Xing, ZHANG Ying, HE Jin-sheng. Primary Studies of Monoclonal Antibody Against Fusion Glycoprotein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2012, 32(02): 63-68.
[4] FU Yuan-hui, HE Jin-sheng, HONG Tao. The Application of Reverse Genetics to the Live-attenuated RSV Vaccine[J]. China Biotechnology, 2011, 31(03): 97-100.
[5] . Isolation of Human Single Chain Antibody against Fusion Protein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2009, 29(09): 0-0.
[6] . Construction and identification of replication deficient recombinant adenovirus expressing M Protein of Human Respiratory Syncytial Virus[J]. China Biotechnology, 2008, 28(5): 6-11.
[7] Ling-zhu Ren . Rescue of FMDV from Contransfecting Full Length Infectious RNA of WFL Strain and Eukaryotic Expression Plasmid of FMDV ORF Gene[J]. China Biotechnology, 2008, 28(4): 27-31.